Abstract:Acinetobacter baumannii is an important pathogenic bacterium with multidrug resistance which causes infections with high mortality rates. In-depth genetic analysis of A. baumannii virulence and drug-resistant genes is highly desirable. In this study, we utilized the conserved pyrF-flanking fragment to rapidly generate uracil auxotrophy hosts with pyrF deleted in model and clinical A. baumannii strains and then introduced the pyrF gene as the selectable and counterselectable marker to establish a series of gene manipulation vectors. For gene deletion with the suicide pyrF-based plasmid, the second-crossover colonies screened with the pyrF/5-fluoroorotic acid (5-FOA) system were obtained more quickly and efficiently than those screened with the sacB/sucrose system. By using the replicative plasmid, the recognized protospacer-adjacent motif (PAM) bias for type I-F CRISPR was experimentally revealed in A. baumannii AYE. Interestingly, interference recognized only the PAM-CC sequence, whereas adaptation priming tolerates 4 PAM sequences. Furthermore, we also performed a rapid and extensive modification of the I-F CRISPR-Cas elements and revealed that the role of double-nucleotide sequence mutants at the end of the repeat could be critical during both CRISPR interference and priming; we also found strong biases for A and demonstrated that adaptation could tolerate certain sequence and size variations of the leader in A. baumannii. In conclusion, this pyrF-based genetic manipulation system was readily applicable and efficient for exploring the genetic characteristics of A. baumannii. IMPORTANCE In this study, we developed the widely applicable and efficient pyrF-based selection and counterselection system in A. baumannii for gene manipulation. In most cases, this pyrF/5-FOA genetic manipulation system was very effective and enabled us to obtain marker-free mutants in a very short period of time. Utilizing this system and the separate mechanism of interference and/or primed adaptation, our experiments revealed some recognition mechanism differences for the key DNA elements of PAM, leader, and repeat in the priming adaptation process of the I-F CRISPR-Cas systems of A. baumannii, which provided some new and original insights for the study of the molecular mechanisms of these processes and laid a foundation for further studies.

LrhA promotes CRISPR-Cas immunity by enhancing primed adaptation in

CdpR Inhibits CRISPR-Cas Adaptive Immunity to Lower Anti-viral Defense While Avoiding Self-Reactivity.

Degenerated CRISPRs widely regulate Cas expression to balance immunity and cost

Calcium-responsive Kinase LadS Modulates Type I-F CRISPR-Cas Adaptive Immunity.

Crosstalk between three CRISPR-Cas types enables primed type VI-A adaptation in Listeria seeligeri

CRISPR-Cas supervises diverse anti-phage defense systems

Cas1 mediates the interference stage in a phage-encoded CRISPR-Cas system

Bacteriophage Cooperation Suppresses CRISPR-Cas3 and Cas9 Immunity

Pro-CRISPR PcrIIC1-associated Cas9 system for enhanced bacterial immunity

Primed acquisition and microhomology-mediated end-joining cooperate to confer specific CRISPR immunity against invasive genetic elements

Broad-spectrum anti-CRISPR proteins facilitate horizontal gene transfer

Cas1 mediates the interference stage in a phage-encoded CRISPR–Cas system

Phage CRISPR-like regulatory RNAs silence bacterial adaptive and innate immunity

Virulence regulates and boosts CRISPR-Cas9 immunity in Group B

Transcriptional Regulator-Mediated Activation of Adaptation Genes Triggers CRISPR De Novo Spacer Acquisition

A pyrF-Based Efficient Genetic Manipulation Platform in Acinetobacter baumannii To Explore the Vital DNA Components of Adaptive Immunity for I-F CRISPR-Cas

Diverse viral cas genes antagonize CRISPR immunity

Coupling Transcriptional Activation of Crispr-Cas System and Dna Repair Genes by Csa3a in Sulfolobus Islandicus

CRISPR-repressed toxin-antitoxin provides population-level immunity against diverse anti-CRISPR elements

Cas9 interaction with the tracrRNA nexus modulates the repression of type II-A CRISPR-cas genes

CRISPR-repressed toxin-antitoxin provides herd immunity against anti-CRISPR elements